Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
May 15 2019 - 5:11PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check
one):
¨
Form 10-K
¨
Form 20-F
¨
Form 11-K
x
Form 10-Q
¨
Form 10-D
¨
Form N-SAR
¨
Form
N-CSR
For Period Ended: March 31, 2019
|
¨
|
Transition Report on Form 10-K
|
|
¨
|
Transition Report on Form 20-F
|
|
¨
|
Transition Report on Form 11-K
|
|
¨
|
Transition Report on Form 10-Q
|
|
¨
|
Transition Report on Form N-SAR
|
For the Transition Period Ended: ______________________________________________________________
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:
_____________________________________________________________________________________________
PART I — REGISTRANT INFORMATION
Medicine Man Technologies, Inc.
Full Name of Registrant
Former Name if Applicable
4880 Havana Street, Suite 201
Address of Principal Executive Office
(Street and Number)
Denver, CO 80239
City, State and Zip Code
PART II — RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable
effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if
appropriate)
|
(a)
|
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
|
|
|
|
x
|
(b)
|
The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar
day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution
report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
|
|
|
|
|
(c)
|
The accountant’s statement or
other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART III — NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F, 11-K,
10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
The compilation, dissemination and review of the information
required to be presented in the Form 10-Q for the fiscal quarter ended March 31, 2019 has imposed requirements that have rendered
timely filing of the Form 10-Q impracticable without undue hardship and expense to the registrant.
PART IV — OTHER INFORMATION
(1) Name and telephone number of person to contact in regard
to this notification
Paul Dickman
|
303
|
371-0387
|
(Name)
|
(Area Code)
|
(Telephone Number)
|
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file
such report(s) been filed ? If answer is no, identify report(s). Yes
x
No
¨
(3) Is it anticipated that any significant change in results
of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included
in the subject report or portion thereof?
Yes
¨
No
x
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
MEDICINE MAN TECHNOLOGIES, INC.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.
|
MEDICINE MAN TECHNOLOGIES, INC.
|
|
|
Date: May 15, 2019
|
By:
|
/s/ Paul Dickman
|
|
|
Paul Dickman
Interim Chief Financial Officer
|
Medicine Man Technologies (CE) (USOTC:SHWZ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medicine Man Technologies (CE) (USOTC:SHWZ)
Historical Stock Chart
From Jul 2023 to Jul 2024